- Investing Ideas
- Canadian Pharmaceuticals & Biotech Healthy potentially undervalued
Canadian Pharmaceuticals & Biotech Healthy potentially undervalued
Results
10
Companies which are potentially undervalued and in an acceptable financial position.
10 companies
High Tide
Market Cap: CA$283.0m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.22
7D
-5.3%
1Y
0%
Cipher Pharmaceuticals
Market Cap: CA$427.7m
Operates as a specialty pharmaceutical company in Canada.
CPH
CA$16.84
7D
0.9%
1Y
27.1%
Decibel Cannabis
Market Cap: CA$66.4m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.12
7D
-4.2%
1Y
64.3%
Curaleaf Holdings
Market Cap: CA$3.0b
Engages in the retail and wholesale of cannabis products in the United States and internationally.
CURA
CA$11.51
7D
-20.9%
1Y
214.5%
Bright Minds Biosciences
Market Cap: CA$943.1m
A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.
DRUG
CA$96.12
7D
-22.1%
1Y
151.2%
Organigram Global
Market Cap: CA$208.1m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.48
7D
-5.7%
1Y
-20.2%
Aurora Cannabis
Market Cap: CA$277.9m
Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
ACB
CA$4.70
7D
-5.2%
1Y
-39.8%
Green Thumb Industries
Market Cap: CA$2.5b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$11.50
7D
4.5%
1Y
60.4%
Trulieve Cannabis
Market Cap: CA$3.2b
Operates as a cannabis retailer in the United States.
TRUL
CA$16.45
7D
28.7%
1Y
204.6%
Medexus Pharmaceuticals
Market Cap: CA$124.5m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$3.91
7D
0.8%
1Y
37.7%